Up until 1985, one treatment for children with growth deficiencies was nonrecombinant human pituitary growth hormone from the pituitary glands of deceased individuals. Such treatment was discontinued when it was discovered that along with growth hormone, the extracts could contain the prion protein that is the cause of Creutzfeldt-Jakob disease (CJD).